Miguel Martins
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Miguel Martins has a total of 183 co-authors. Here are the top co-authors by number of shared publications:
- Francisco Mendes
Department of Gastroenterology, São João University Hospital, 4200-319 Porto, Portugal
32 shared publications - Miguel Mascarenhas
Department of Community Medicine, Information and Health Decision Sciences (MEDCIDS), Faculty of Medicine, University of Porto, 4099-002 Porto, Portugal
32 shared publications - Guilherme Macedo
Department of Gastroenterology, São João University Hospital, 4200-319 Porto, Portugal
29 shared publications - Pedro Cardoso
Department of Gastroenterology, São João University Hospital, Alameda Professor Hernâni Monteiro, 4200-427 Porto, Portugal
26 shared publications - Tiago Ribeiro
Gastroenterology Department, Centro Hospitalar Universitário de São João, Porto, Portugal
21 shared publications - João Afonso
Precision Medicine Unit, Department of Gastroenterology, São João University Hospital, Alameda Professor Hernâni Monteiro, 4200-427 Porto, Portugal
17 shared publications
Latest Publications
- 5 August 2026
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 20 (8)
Efficacy, safety, and outcomes of endoscopic submucosal dissection for inflammatory bowel disease-associated colorectal neoplasia: a systematic review and meta-analysis comparing Asian and Western outcomes
Introduction: Endoscopic submucosal dissection (ESD) is increasingly being adopted worldwide for the treatment of colorectal neoplasia. However, its role in patients with inflammatory bowel disease (IBD) remains debatable, due to chronic inflammation-related fibrosis, potentially affecting outcomes. This study aimed to assess the efficacy and safety of ESD for colorectal neoplastic lesions in IBD patients, comparing Asian and Western settings. Methods: A systematic review was conducted by searching MEDLINE and Web of Science until January 2025, in accordance to MOOSE guidelines. We included primary studies reporting ESD performance in IBD patients. We performed random-effects meta-analysis for several outcomes, including en-bloc, R0, and curative resection rates, frequency of adverse events (post-procedural bleeding and perforation), local recurrence, and need for additional surgery after ESD. Certainty of evidence was assessed using GRADE. Results: We included 20 studies (565 patients and 732 lesions). The meta-analytical frequencies of en-bloc, R0, and curative resection rates were 95.7% (95% CI = 93.5-97.9%; I2 = 60.1%), 84.6% (95% CI = 79.4-90.1%; I2 = 68.9%), and 83.9% (95% CI = 76.3-92.4%; I2 = 75.9%), respectively. Postprocedural bleeding and perforation occurred in 7.0% (95% CI = 4.4-11.2%; I2 = 16.9%) and 7.9% (95% CI = 5.3-11.9%; I2 = 2.4%) of cases, respectively. Local recurrence frequency was 5.3% (95% CI = 3.5-7.9%; I2 = 0%). The meta-analytical need for additional surgery was 13.3% (95% CI = 9.5-18.1%; I2 = 42.5%). No differences were found between Asian and Western studies for any outcome. The certainty of evidence was considered “low” in four outcomes and “very low” in the remaining outcomes. Conclusion: ESD may be feasible and safe for treating IBD-associated colorectal neoplasias, but the available evidence is limited. Similar results were observed between Asian and Western studies.
- 5 August 2026
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 20 (8)
Efficacy, safety, and outcomes of endoscopic submucosal dissection for inflammatory bowel disease-associated colorectal neoplasia: a systematic review and meta-analysis comparing Asian and Western outcomes
Introduction: Endoscopic submucosal dissection (ESD) is increasingly being adopted worldwide for the treatment of colorectal neoplasia. However, its role in patients with inflammatory bowel disease (IBD) remains debatable, due to chronic inflammation-related fibrosis, potentially affecting outcomes. This study aimed to assess the efficacy and safety of ESD for colorectal neoplastic lesions in IBD patients, comparing Asian and Western settings. Methods: A systematic review was conducted by searching MEDLINE and Web of Science until January 2025, in accordance to MOOSE guidelines. We included primary studies reporting ESD performance in IBD patients. We performed random-effects meta-analysis for several outcomes, including en-bloc, R0, and curative resection rates, frequency of adverse events (post-procedural bleeding and perforation), local recurrence, and need for additional surgery after ESD. Certainty of evidence was assessed using GRADE. Results: We included 20 studies (565 patients and 732 lesions). The meta-analytical frequencies of en-bloc, R0, and curative resection rates were 95.7% (95% CI = 93.5-97.9%; I2 = 60.1%), 84.6% (95% CI = 79.4-90.1%; I2 = 68.9%), and 83.9% (95% CI = 76.3-92.4%; I2 = 75.9%), respectively. Postprocedural bleeding and perforation occurred in 7.0% (95% CI = 4.4-11.2%; I2 = 16.9%) and 7.9% (95% CI = 5.3-11.9%; I2 = 2.4%) of cases, respectively. Local recurrence frequency was 5.3% (95% CI = 3.5-7.9%; I2 = 0%). The meta-analytical need for additional surgery was 13.3% (95% CI = 9.5-18.1%; I2 = 42.5%). No differences were found between Asian and Western studies for any outcome. The certainty of evidence was considered “low” in four outcomes and “very low” in the remaining outcomes. Conclusion: ESD may be feasible and safe for treating IBD-associated colorectal neoplasias, but the available evidence is limited. Similar results were observed between Asian and Western studies.
- Open Access
- 29 July 2026
- Published by Elsevier in Gastro Hep Advances
- Vol. 5 (11)
Artificial Intelligence for Anal Cancer Screening: Multicenter Multicontinental Validation of a Trinary Model in High-Resolution Anoscopy
- 29 July 2026
- Published by Elsevier in Gastro Hep Advances
- Vol. 5 (11)
Open AccessArtificial Intelligence for Anal Cancer Screening: Multicenter Multicontinental Validation of a Trinary Model in High-Resolution Anoscopy
- Open Access
- 17 March 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (6) , 2268
Real-Time Application of Artificial Intelligence for Automatic Detection of High-Grade Squamous Intraepithelial Lesions During High-Resolution Anoscopy
Background: High-resolution anoscopy (HRA) is the gold standard for anal cancer screening, but its interpretation is challenging and operator-dependent. Artificial intelligence (AI) may increase diagnostic yield, but most studies have focused on differentiating low-grade and high-grade squamous intraepithelial lesions (LSIL and HSIL, respectively) in still frames, with no clinical application reported. Methods: We describe the first real-time use of deep learning, demonstrated in three patients undergoing HRA for anal cancer screening, at a high-volume American referral center. When an area suggestive of HSIL appeared, a YOLO-based object detection model generated a bounding box. Results: The model detected only histologically confirmed HSIL and did not activate when no lesions or only LSIL were present. Conclusions: This report suggests that real-time AI-enhanced HRA is feasible and may improve lesion detection and differentiation, potentially representing a significant step forward in this demanding field, although multicentric validation studies are still needed.
- 17 March 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (6) , 2268
Open AccessReal-Time Application of Artificial Intelligence for Automatic Detection of High-Grade Squamous Intraepithelial Lesions During High-Resolution Anoscopy
Background: High-resolution anoscopy (HRA) is the gold standard for anal cancer screening, but its interpretation is challenging and operator-dependent. Artificial intelligence (AI) may increase diagnostic yield, but most studies have focused on differentiating low-grade and high-grade squamous intraepithelial lesions (LSIL and HSIL, respectively) in still frames, with no clinical application reported. Methods: We describe the first real-time use of deep learning, demonstrated in three patients undergoing HRA for anal cancer screening, at a high-volume American referral center. When an area suggestive of HSIL appeared, a YOLO-based object detection model generated a bounding box. Results: The model detected only histologically confirmed HSIL and did not activate when no lesions or only LSIL were present. Conclusions: This report suggests that real-time AI-enhanced HRA is feasible and may improve lesion detection and differentiation, potentially representing a significant step forward in this demanding field, although multicentric validation studies are still needed.
- Open Access
- 20 January 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (2) , 334
Robotic Capsule Endoscopy: Simultaneous Gastric and Enteric Evaluation in Real-World Practice
Background/Objectives: Robotic capsule endoscopy (RCE) is an emerging technology that combines magnetically controlled gastric navigation with conventional capsule enteroscopy (CE), enabling a minimally invasive, comprehensive evaluation of the upper- and mid-gastrointestinal tract. This study aimed to characterize the real-world implementation and diagnostic performance of RCE in a European tertiary referral center. Methods: A retrospective, single-center analysis was conducted on adult patients (≥18 years) who underwent RCE (Omom RC) between June 2023 and July 2025. Eligible patients had a clinical indication for small bowel CE and a concurrent requirement for diagnostic gastroscopy or reassessment of known gastric lesions. The RCE protocol comprised an initial robotic-guided gastric examination followed by passive transit through the small bowel. Results: A total of 85 patients were included (52% female), with a median age of 49 years (IQR 40–64). The most common indications were suspected or established inflammatory bowel disease (57%) and iron deficiency anemia (31%). Gastric preparation was rated at least fair in 98% of cases, with good preparation in 38%. Median gastric transit time was 74 min (IQR 35–106). Relevant gastric findings were identified in 39 cases (46%), namely polyps (18%) and angiectasias (8%, including one with active bleeding), in addition to signs of chronic gastritis. Thirteen patients underwent subsequent endoscopy, resulting in seven therapeutic procedures. Small bowel findings were present in 60 patients (71%), including P3 (active bleeding) in 3% and P2 lesions (angiectasias, ulcers, tumors, varices) in 39%. One moderate adverse event occurred: small bowel capsule retention in a patient with multifocal neuroendocrine tumor and ileostomy, requiring endoscopic intervention. Conclusions: Robotic capsule endoscopy is a feasible tool for dual-region gastrointestinal evaluation. It enables high-quality gastric visualization, facilitates early detection of clinically actionable lesions, and maintains the diagnostic yield expected from standard small bowel CE. These findings support the integration of RCE into diagnostic pathways for patients requiring simultaneous gastric and small bowel assessment.
- 20 January 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (2) , 334
Open AccessRobotic Capsule Endoscopy: Simultaneous Gastric and Enteric Evaluation in Real-World Practice
Background/Objectives: Robotic capsule endoscopy (RCE) is an emerging technology that combines magnetically controlled gastric navigation with conventional capsule enteroscopy (CE), enabling a minimally invasive, comprehensive evaluation of the upper- and mid-gastrointestinal tract. This study aimed to characterize the real-world implementation and diagnostic performance of RCE in a European tertiary referral center. Methods: A retrospective, single-center analysis was conducted on adult patients (≥18 years) who underwent RCE (Omom RC) between June 2023 and July 2025. Eligible patients had a clinical indication for small bowel CE and a concurrent requirement for diagnostic gastroscopy or reassessment of known gastric lesions. The RCE protocol comprised an initial robotic-guided gastric examination followed by passive transit through the small bowel. Results: A total of 85 patients were included (52% female), with a median age of 49 years (IQR 40–64). The most common indications were suspected or established inflammatory bowel disease (57%) and iron deficiency anemia (31%). Gastric preparation was rated at least fair in 98% of cases, with good preparation in 38%. Median gastric transit time was 74 min (IQR 35–106). Relevant gastric findings were identified in 39 cases (46%), namely polyps (18%) and angiectasias (8%, including one with active bleeding), in addition to signs of chronic gastritis. Thirteen patients underwent subsequent endoscopy, resulting in seven therapeutic procedures. Small bowel findings were present in 60 patients (71%), including P3 (active bleeding) in 3% and P2 lesions (angiectasias, ulcers, tumors, varices) in 39%. One moderate adverse event occurred: small bowel capsule retention in a patient with multifocal neuroendocrine tumor and ileostomy, requiring endoscopic intervention. Conclusions: Robotic capsule endoscopy is a feasible tool for dual-region gastrointestinal evaluation. It enables high-quality gastric visualization, facilitates early detection of clinically actionable lesions, and maintains the diagnostic yield expected from standard small bowel CE. These findings support the integration of RCE into diagnostic pathways for patients requiring simultaneous gastric and small bowel assessment.
- Open Access
- 13 January 2026
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 14 (CP)
Automated assessment of small bowel and colon cleansing in enteroscopy using a convolutional neural network
Device-assisted enteroscopy (DAE) offers a comprehensive examination of the gastrointestinal tract, yet its diagnostic and therapeutic success is dependent on adequate bowel preparation. Current methods for assessing preparation quality are subjective and limited to specific gastrointestinal segments. Although prior research explored artificial intelligence models for colon preparation classification, this study aimed to develop a convolutional neural network (CNN) for automatic evaluation of bowel cleanliness in DAE, addressing both small bowel and colon cleansing. We retrospectively analyzed 28 procedures (single balloon, double-balloon, and motorized spiral enteroscopy from January 2023 to May 2024). Bowel preparation was graded as excellent (≥ 90% visible mucosa), satisfactory (50%-90%), or unsatisfactory (< 50%). A dataset of 88,623 images (training: 90%, testing: 10%) was used, covering both small bowel and colon areas. CNN performance was evaluated against expert consensus using sensitivity, specificity, accuracy, and area under a receiver operating characteristic (AUC-ROC). The CNN demonstrated the following performance metrics: excellent cleansing (sensitivity: 97.8%, specificity: 80.3%, accuracy: 90.6%, AUC-ROC: 0.95), satisfactory cleansing (sensitivity: 81.8%, specificity: 97.9%, accuracy: 92.7%, AUC-ROC: 0.95), and unsatisfactory cleansing (sensitivity: 68.7%, specificity: 99.5%, accuracy: 96.8%, AUC-ROC: 0.96). Current bowel cleanliness assessment methods are subjective and region-specific. This study presents the first CNN capable of panendoscopic bowel cleanliness evaluation during DAE, achieving high accuracy and demonstrating potential for real-time clinical application. This study marks a key step toward standardizing cleanliness assessment and endoscopy quality improvement.
- 13 January 2026
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 14 (CP)
Open AccessAutomated assessment of small bowel and colon cleansing in enteroscopy using a convolutional neural network
Device-assisted enteroscopy (DAE) offers a comprehensive examination of the gastrointestinal tract, yet its diagnostic and therapeutic success is dependent on adequate bowel preparation. Current methods for assessing preparation quality are subjective and limited to specific gastrointestinal segments. Although prior research explored artificial intelligence models for colon preparation classification, this study aimed to develop a convolutional neural network (CNN) for automatic evaluation of bowel cleanliness in DAE, addressing both small bowel and colon cleansing. We retrospectively analyzed 28 procedures (single balloon, double-balloon, and motorized spiral enteroscopy from January 2023 to May 2024). Bowel preparation was graded as excellent (≥ 90% visible mucosa), satisfactory (50%-90%), or unsatisfactory (< 50%). A dataset of 88,623 images (training: 90%, testing: 10%) was used, covering both small bowel and colon areas. CNN performance was evaluated against expert consensus using sensitivity, specificity, accuracy, and area under a receiver operating characteristic (AUC-ROC). The CNN demonstrated the following performance metrics: excellent cleansing (sensitivity: 97.8%, specificity: 80.3%, accuracy: 90.6%, AUC-ROC: 0.95), satisfactory cleansing (sensitivity: 81.8%, specificity: 97.9%, accuracy: 92.7%, AUC-ROC: 0.95), and unsatisfactory cleansing (sensitivity: 68.7%, specificity: 99.5%, accuracy: 96.8%, AUC-ROC: 0.96). Current bowel cleanliness assessment methods are subjective and region-specific. This study presents the first CNN capable of panendoscopic bowel cleanliness evaluation during DAE, achieving high accuracy and demonstrating potential for real-time clinical application. This study marks a key step toward standardizing cleanliness assessment and endoscopy quality improvement.
- Open Access
- 8 January 2026
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 58 (S 01) , E276-E278
Hybrid endoscopic rescue following endoscopic ultrasound-guided choledochoduodenostomy
An 88-year-old man with biliary obstruction caused by a complex cystic lesion in the pancreatic head, considered inoperable due to significant comorbidities, was referred for endoscopic biliary drainage. Following failed endoscopic retrograde cholangiopancreatography, endoscopic ultrasound (EUS)-guided cholecystogastrostomy was performed, as the cystic duct was patent. Two years later, he presented with cholangitis from recurrent biliary obstruction due to disease progression ([Fig. 1]). EUS revealed common bile duct (CBD) dilation (~14 mm), caused by the pancreatic head lesion ([Fig. 2]). Left intrahepatic bile duct dilation was minimal, precluding hepaticogastrostomy. Decision was to perform EUS-guided choledochoduodenostomy. The first attempt with a 6 × 8 mm electrocautery-tip lumen-apposing metal stent (Axios, Boston Scientific) using the free-hand technique resulted in a type I misdeployment [1]. The stent was removed, and the duodenal wall defect was closed with two through-the-scope clips ([Fig. 3]). The second attempt involved CBD puncture using a 19G needle (Expect Slimline, Boston Scientific) for cholangiography and duct distension, fistula creation using an 8.5 Fr cystotome (Cysto-Gastro-Set, Endo-Flex), and the placement of the 10 × 60 mm fully covered metal biliary stent (Evolution, Cook Medical); however, the stent migrated distally during deployment ([Fig. 4]). Despite multiple attempts, CBD re-canulation using guidewire manipulation was not achieved. Using a therapeutic endoscope (Olympus GIF-2TH180), a cholangioscope (SpyGlass DS II, Boston Scientific) was advanced through the fistula into retroperitoneal space, enabling access to the bile duct and stent placement over a guidewire ([Video 1]). Final endoscopic and fluoroscopic imaging confirmed pneumobilia and adequate bile/contrast drainage ([Fig. 5]). Patient recovered rapidly, being discharged on post-procedure day 3. EUS-guided biliary drainage is an effective alternative when transpapillary drainage is not feasible, although adverse events can be significant [2]. To our knowledge, the use of cholangioscopy for biliary fistula salvage after EUS-choledochoduodenostomy has not been previously reported [3]. This hybrid NOTES-based approach may represent a valuable rescue option in such cases. Endoscopy_UCTN_Code_CPL_1AL_2AD Article published online: 24 February 2026 © 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 8 January 2026
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 58 (S 01) , E276-E278
Open AccessHybrid endoscopic rescue following endoscopic ultrasound-guided choledochoduodenostomy
An 88-year-old man with biliary obstruction caused by a complex cystic lesion in the pancreatic head, considered inoperable due to significant comorbidities, was referred for endoscopic biliary drainage. Following failed endoscopic retrograde cholangiopancreatography, endoscopic ultrasound (EUS)-guided cholecystogastrostomy was performed, as the cystic duct was patent. Two years later, he presented with cholangitis from recurrent biliary obstruction due to disease progression ([Fig. 1]). EUS revealed common bile duct (CBD) dilation (~14 mm), caused by the pancreatic head lesion ([Fig. 2]). Left intrahepatic bile duct dilation was minimal, precluding hepaticogastrostomy. Decision was to perform EUS-guided choledochoduodenostomy. The first attempt with a 6 × 8 mm electrocautery-tip lumen-apposing metal stent (Axios, Boston Scientific) using the free-hand technique resulted in a type I misdeployment [1]. The stent was removed, and the duodenal wall defect was closed with two through-the-scope clips ([Fig. 3]). The second attempt involved CBD puncture using a 19G needle (Expect Slimline, Boston Scientific) for cholangiography and duct distension, fistula creation using an 8.5 Fr cystotome (Cysto-Gastro-Set, Endo-Flex), and the placement of the 10 × 60 mm fully covered metal biliary stent (Evolution, Cook Medical); however, the stent migrated distally during deployment ([Fig. 4]). Despite multiple attempts, CBD re-canulation using guidewire manipulation was not achieved. Using a therapeutic endoscope (Olympus GIF-2TH180), a cholangioscope (SpyGlass DS II, Boston Scientific) was advanced through the fistula into retroperitoneal space, enabling access to the bile duct and stent placement over a guidewire ([Video 1]). Final endoscopic and fluoroscopic imaging confirmed pneumobilia and adequate bile/contrast drainage ([Fig. 5]). Patient recovered rapidly, being discharged on post-procedure day 3. EUS-guided biliary drainage is an effective alternative when transpapillary drainage is not feasible, although adverse events can be significant [2]. To our knowledge, the use of cholangioscopy for biliary fistula salvage after EUS-choledochoduodenostomy has not been previously reported [3]. This hybrid NOTES-based approach may represent a valuable rescue option in such cases. Endoscopy_UCTN_Code_CPL_1AL_2AD Article published online: 24 February 2026 © 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- Open Access
- 5 January 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (1) , 401
Artificial Intelligence and FLIP Panometry—Automated Classification of Esophageal Motility Patterns
Background/Objectives: Functional lumen imaging probe (FLIP) panometry allows real-time assessment of the esophagogastric junction opening and esophageal body contractile activity during an endoscopic procedure. Despite the development of the Dallas Consensus, FLIP panometry analysis remains complex. Artificial intelligence (AI) models have proven their benefit in high-resolution esophageal manometry; however, data on their role in FLIP panometry are scarce. This study aims to develop an AI model for automatic classification of motility patterns during a FLIP panometry exam. Methods: A total of 105 exams from five centers from both the European and American continents were included. Several machine learning models were trained and evaluated for detection of FLIP panometry patterns. Each exam was classified with an expert consensus-based decision according to the Dallas Consensus, with division into a training and testing dataset in a patient-split design. Models’ performance was evaluated through their accuracy and area under the receiver-operating characteristic curve (AUC-ROC). Results: Pathological planimetry patterns were identified by an AdaBoost Classifier with 84.9% accuracy and a mean AUC-ROC of 0.92. Random Forest identified disorders of the esophagogastric junction opening with 86.7% accuracy and an AUC-ROC of 0.973. The Gradient Boosting Classifier identified disorders of the contractile response with 86.0% accuracy and an AUC-ROC of 0.933. Conclusions: In this study, integrating exams with different probe sizes and demographic contexts, a machine learning model accurately classified FLIP panometry exams according to the Dallas Consensus. AI-driven FLIP panometry could revolutionize the approach to this exam during an endoscopic procedure, optimizing exam accuracy, standardization, and accessibility, and transforming patient management.
- 5 January 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (1) , 401
Open AccessArtificial Intelligence and FLIP Panometry—Automated Classification of Esophageal Motility Patterns
Background/Objectives: Functional lumen imaging probe (FLIP) panometry allows real-time assessment of the esophagogastric junction opening and esophageal body contractile activity during an endoscopic procedure. Despite the development of the Dallas Consensus, FLIP panometry analysis remains complex. Artificial intelligence (AI) models have proven their benefit in high-resolution esophageal manometry; however, data on their role in FLIP panometry are scarce. This study aims to develop an AI model for automatic classification of motility patterns during a FLIP panometry exam. Methods: A total of 105 exams from five centers from both the European and American continents were included. Several machine learning models were trained and evaluated for detection of FLIP panometry patterns. Each exam was classified with an expert consensus-based decision according to the Dallas Consensus, with division into a training and testing dataset in a patient-split design. Models’ performance was evaluated through their accuracy and area under the receiver-operating characteristic curve (AUC-ROC). Results: Pathological planimetry patterns were identified by an AdaBoost Classifier with 84.9% accuracy and a mean AUC-ROC of 0.92. Random Forest identified disorders of the esophagogastric junction opening with 86.7% accuracy and an AUC-ROC of 0.973. The Gradient Boosting Classifier identified disorders of the contractile response with 86.0% accuracy and an AUC-ROC of 0.933. Conclusions: In this study, integrating exams with different probe sizes and demographic contexts, a machine learning model accurately classified FLIP panometry exams according to the Dallas Consensus. AI-driven FLIP panometry could revolutionize the approach to this exam during an endoscopic procedure, optimizing exam accuracy, standardization, and accessibility, and transforming patient management.
- Open Access
Correction: Saraiva et al. Deep Learning and High-Resolution Anoscopy: Development of an Interoperable Algorithm for the Detection and Differentiation of Anal Squamous Cell Carcinoma Precursors—A Multicentric Study. Cancers 2024, 16, 1909
There were errors in the original publication
- Open Access
- 17 November 2025
- Published by S. Karger AG in GE - Portuguese Journal of Gastroenterology
- p. 1-4
Intestinal Subocclusion – An Unexpected Diagnosis in a Common Clinical Presentation: A Case Report
- 17 November 2025
- Published by S. Karger AG in GE - Portuguese Journal of Gastroenterology
- p. 1-4
Open AccessIntestinal Subocclusion – An Unexpected Diagnosis in a Common Clinical Presentation: A Case Report